Search

Showing total 182 results
182 results

Search Results

101. Epidemiological Characteristics of COVID-19 Infection in the Republic of Srpska: a Hundred Days Survey.

102. A Review on the Novel Coronavirus Disease based on In-silico Analysis of Various Drugs and Target Proteins.

103. A Review on the Novel Coronavirus Disease based on In-silico Analysis of Various Drugs and Target Proteins.

104. Noticias sobre Covid-19 y 2019-nCoV en medios de comunicación de España: el papel de los medios digitales en tiempos de confinamiento.

105. COVID-19 IN PRIMARY HEALTHCARE.

106. COVID-19 and newborn health: systematic review.

107. How we have been productive when Coronavirus locked us out of University.

108. Health Sector Responses to the COVID-19 Pandemic in Ontario, Canada - January to May 2020.

109. A PANDEMIA DA COVID-19 NA FRONTEIRA AMAZÔNICA: UMA ANÁLISE PRELIMINAR NAS CIDADES-GÊMEAS DE TABATINGA E LETICIA.

110. Scientific evidence on the origin of SARS-CoV-2.

111. Vasculitis and COVID-19: what do we have to know?

112. COVID-19 coagulopathy: towards the understanding of pathogenesis.

113. COVID-19 and gender differences: lights and shadows.

114. Hypovitaminosis D and COVID-19.

115. Pulmonary involvement and cytochemical storm: beyond SARS-CoV-2 pneumoniae.

116. Editorial: Special Section on Modeling and Simulation in Disaster and Emergency Management.

117. A methodological proposal to evaluate the health hazard scenario from COVID-19 in Italy.

118. Pandemic tattoos: A review of 329 #covidtattoo on Instagram.

119. Air pollution impact on the Covid-19 mortality in Iran considering the comorbidity (obesity, diabetes, and hypertension) correlations.

120. Wastewater-based epidemiology approach: The learning lessons from COVID-19 pandemic and the development of novel guidelines for future pandemics.

121. SARS-CoV-2 and other pathogenic microorganisms in the environment.

122. COVID-19 and environmental concerns: A rapid review.

123. Antiviral peptides from aquatic organisms: Functionality and potential inhibitory effect on SARS-CoV-2.

124. Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on "Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13 , 1199"

125. Influence and analysis of ambulance on the containment of COVID-19 in China.

126. Novel coronavirus disease 2019 (COVID-19) pandemic: From transmission to control with an interdisciplinary vision.

127. Population Mobility and the Transmission Risk of the COVID-19 in Wuhan, China.

128. Applications of Big Data Analytics to Control COVID-19 Pandemic.

129. Quantitative assessment of U.S. bulk power systems and market operations during the COVID-19 pandemic.

130. Effects of the COVID-19 Pandemic on Energy Systems and Electric Power Grids—A Review of the Challenges Ahead.

131. SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets.

132. A Review of the State of the Art in Non-Contact Sensing for COVID-19.

133. A robust numerical two-level second-order explicit approach to predicting the spread of Covid-2019 pandemic with undetected infectious cases.

134. Maskne : The Epidemic within the Pandemic: From Diagnosis to Therapy.

135. COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference.

136. From SARS to COVID-19: Digital infrastructures of surveillance and segregation in exceptional times.

137. Spatial variability of COVID-19 and its risk factors in Nigeria: A spatial regression method.

138. Innovative vaccine platforms against infectious diseases: Under the scope of the COVID-19 pandemic.

139. The next future of COVID-19 epidemic in Italy.

140. Hospital discharge and return to the community: is it so simple?

141. A survey on artificial intelligence approaches in supporting frontline workers and decision makers for the COVID-19 pandemic.

142. Application of a novel mathematical model to identify intermediate hosts of SARS-CoV-2.

143. What we know and what we need to know about the origin of SARS-CoV-2.

144. Applications of machine learning and artificial intelligence for Covid-19 (SARS-CoV-2) pandemic: A review.

145. Optimal Control Design of Impulsive SQEIAR Epidemic Models with Application to COVID-19.

146. Analysis on novel coronavirus (COVID-19) using machine learning methods.

147. A classification of countries and regions by degree of the spread of coronavirus based on statistical criteria.

148. Transformation of Business Models in Spa Enterprises for Medical Purposes in Situations of Epidemic Threats.

149. A Model for the Spread of Infectious Diseases with Application to COVID-19.

150. Critical Aspects Concerning the Development of a Pooling Approach for SARS-CoV-2 Diagnosis Using Large-Scale PCR Testing.